Meperidine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Meperidine Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 05/30/2025. Reported reason: Shortage of an active ingredient
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6054-25
- Dosage Form
- Injection
- Presentation
- Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)
- Initial Posting
- 05/30/2025
- Revised Date
Reason
Shortage of an active ingredient